4,4,5,5-Tetramethyl-2-propyl-1,3,2-dioxaborolane, 98%, 5g

1-(Oxan-4-yl)-2-oxo-1,2-dihydropyrimidine-5-carboxylic acid, 1g

3-Bromo-5-(prop-1-en-2-yl)pyridine, 95.0%, 1g

Ethyl 3-[(cyclopropylmethyl)amino]propanoate, 97%, 1g

2-Hydroxy-[1,1'-biphenyl]-3-carbaldehyde, 95.0%, 250mg

Depósitos de reactivos para pipetas de 8/12 canales, no estériles, 50 piezas, 50 piezas

tert-Butyl 4,4-difluoropiperidine-1-carboxylate, 95.0%, 5g

Terephthalbis(p-phenetidine)>98.0%(GC)(N)25g

2,4-Pyridinedicarboxylic Acid>98.0%(GC)25g

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 10g

tert-Butyl 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 250mg

2,2,5,5-Tetrakis(hydroxymethyl)cyclopentan-1-one, 98%, 100mg

[S(R)]-N-[(R)-[2-(Diadamantanphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide, 95%, 100mg